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Introduction
Thus far, echocardiography has a pivotal role in cardiac 
resynchronisation therapy (CRT), underlined by the wide 
field of application, determining cardiac function and spe-
cifically left ventricular (LV) function and response due 
to desired reverse electro-mechanical remodelling. The 
range of tools, from brightness mode or Doppler imaging to 
deformation imaging, offers the possibility of patient selec-
tion and response prediction, lead placement optimisation 
strategies and optimisation of device configurations (Fig. 1; 
[1–3]). Multiple single-centre studies have advocated the 
value of echocardiography in patient selection and deter-
mining prognosis [4–6]. However, limitations are known, 
as the PROSPECT study showed a limited value regarding 
response prediction, and EchoCRT gave insight into the 
potential negative effects of echocardiographic parameters 
as selection criteria [3, 7]. Moreover, echocardiography 
can have a relatively substantial measurement error and not 
every patient is suitable for adequate echocardiographic 
volume assessment, especially in non-expert hands [8]. 
The question arises whether echocardiography is a useful 
imaging tool for evaluation of CRT patients, or are its short-
comings impeding clinical decision making? This review 
reflects on the role of echocardiography in the field of CRT, 
are they friends or foes?
Abstract Echocardiography is used in cardiac resynchro-
nisation therapy (CRT) to assess cardiac function, and in 
particular left ventricular (LV) volumetric status, and pre-
diction of response. Despite its widespread applicability, 
LV volumes determined by echocardiography have inherent 
measurement errors, interobserver and intraobserver vari-
ability, and discrepancies with the gold standard magnetic 
resonance imaging. Echocardiographic predictors of CRT 
response are based on mechanical dyssynchrony. How-
ever, parameters are mainly tested in single-centre studies 
or lack feasibility. Speckle tracking echocardiography can 
guide LV lead placement, improving volumetric response 
and clinical outcome by guiding lead positioning towards 
the latest contracting segment. Results on optimisation of 
CRT device settings using echocardiographic indices have 
so far been rather disappointing, as results suffer from 
noise. Defining response by echocardiography seems valid, 
although re-assessment after 6 months is advisable, as pa-
tients can show both continuous improvement as well as 
deterioration after the initial response. Three-dimensional 
echocardiography is interesting for future implications, 
as it can determine volume, dyssynchrony and viability 
in a single recording, although image quality needs to be 
adequate. Deformation patterns from the septum and the 
derived parameters are promising, although validation in 
a multicentre trial is required. We conclude that echocar-
diography has a pivotal role in CRT, although clinicians 
should know its shortcomings.
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Patient selection
Left ventricular ejection fraction
Echocardiography gives insight into the cardiac anatomy 
and valvular dysfunction of CRT patients. Its main role in 
CRT is determining cardiac function and especially LV vol-
umes and ejection fraction (LVEF). International guidelines 
on CRT define a cut-off for LVEF at ≤ 35 %, independent 
of the imaging tool used [9, 10]. A meta-analysis of ran-
domised trials on the effects of CRT on morbidity and mor-
tality has underlined this cut-off. A reduced benefit or even 
adverse effect in patients with an LVEF above the cut-off 
was observed, although the large confidence interval might 
indicate that a subgroup of patients with LVEF > 35 % do 
benefit (hazard ratio for all-cause mortality: 0.28–2.00) 
[11]. This could be due to an overestimation of LVEF by 
echocardiography. A sub-analysis of the PROSPECT study 
advocated the benefit of CRT in patients above the threshold 
[12]. The threshold for response to CRT is probably more a 
continuum than binary.
Although the biplane Simpson’s method is the most 
robust method to determine LV volume and function for 
echocardiography, intraobserver and interobserver variabil-
ity can be high, with reported differences in LVEF of up 
to 18 % (Bland-Altman limits of agreement or two standard 
deviations) [8]. A study compared LVEF determined by a 
recruiting centre to an echocardiography core lab. The cor-
relation coefficient was fair among 413 patients (R2: 0.69). 
A mean difference of 0.2 % was found, although a wide 
confidence interval was observed (95 % CI: − 17.4–17.8 %). 
Moreover, 20 % of all patients would have been reclassified 
by another centre, using a cut-off for LVEF of 30 % [13]. 
These results underline the limitations of echocardiography 
for a strict cut-off, beside the need for core lab activities.
Volumes derived with echo are underestimated com-
pared with ‘gold standard’ magnetic resonance imaging 
(MRI) [14, 15]. Nevertheless a meta-analysis found a mean 
difference between the two modalities of close to 0 %, 
although a large spread and heterogeneity between studies 
was observed [8]. Assessment of LVEF by MRI and echo-
cardiography shows opposing results for CRT eligibility in 
28 % of patients, using the guideline cut-off. Compared with 
MRI, echocardiography underestimated both end-diastolic 
and end-systolic volume, while overestimating LVEF [15]. 
As most large multicentre trials on the selection of patients 
for CRT used echocardiographic-derived volumes, cut-offs 
cannot be directly translated to other imaging techniques.
Averaging of several measured beats improves accuracy 
in general, and is applicable to all patients and specifically 
KEY MESSAGE  Echocardiography plays an important role in patient selection, optimization, and the assessment of
                               response of cardiac resynchronisation therapy.
The application of echocardiography in CRT. Echocardiography is mainly used to asses cardiac function and
select patients by volumetric and subsequent ejection fraction assessment. Response is defined by determining
change in volumetric status after a period of CRT and reverse remodeling. Dyssynchrony parameters based on
Doppler measurements and/or strain analysis can further improve patient selection. Doppler measurements can
also optimise CRT settings (i.e. atrio- and interventricular delays), while strain analysis can support LV lead
optimisation strategies. 
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response (> 15 % decrease in end-systolic volume) advocate 
the use of mechanical dyssynchrony parameters, on top of 
existing criteria [21, 22]. However, multicentre trials and 
meta-analysis have failed to show an added value of several 
dyssynchrony indices, although interventricular mechanical 
dyssynchrony (IVMD) was associated with increased sur-
vival in the CARE-HF study [3, 23, 24]. Other parameters 
(systolic rebound stretch of the septum (SRSsept), septal 
flash and apical rocking) are only proven in single-centre 
studies [4, 25, 26].
Visual assessment or ‘eye-balling’ of mechanical dyssyn-
chrony is perhaps the most feasible method for routine clini-
cal applications. Two parameters are known: apical rocking 
and septal flash (Fig. 2) Both are known to have a high 
specificity for predicting response [25, 26]. Apical rocking 
is the apical transverse motion due to an inhomogeneity of 
myocardial contraction and function, and requires an api-
cal four chamber view with a visible apex. LBBB causes 
early septal contraction which moves the apex towards the 
septum, while delayed lateral wall contraction subsequently 
‘rocks’ the apex towards the lateral side. Szulik et al. proved 
the predictive value for volumetric response, with compa-
rable strength for both visually assessed and automatically 
quantified apical rocking [25]. Ghani et al. confirmed these 
results and further showed that apical rocking predicts long-
term clinical outcome in terms of hospitalisation for heart 
failure [6]. Septal flash shows similar results. A septal flash 
is a short inward septal motion, occurring due to early sep-
tal contraction, interrupted by delayed free wall contraction. 
Parsai et al. found the presence of septal flash to be predic-
tive for both clinical and volumetric response [27]. On top 
of known predictors, the value of septal flash in prediction 
models was significant [22].
IVMD is the delay in onset of outflow between the left 
and right ventricle. Delayed activation and subsequent con-
traction of the LV free wall due to LBBB leads to a delayed 
rise in LV pressure and outflow. LV dyssynchrony therefore 
lengthens the LV pre-ejection period, increasing IVMD, 
while ‘normal’ right ventricular (RV) activation leads to a 
fast rise in pressure and outflow through the RV outflow 
tract. IVMD can, however, be confounded by reduced RV 
function and a lengthened RV pre-ejection period. It can 
be easily measured using pulsed-wave Doppler signals 
obtained in any standard echocardiogram. IVMD reflects 
dyssynchrony of interventricular dynamics, by subtracting 
the difference in onset between QRSonset and flow through 
both the left and right ventricular outflow tract (LV and 
RV pre-ejection period, respectively). Although a cut-off 
of 40 ms is used to determine dyssynchrony, IVMD has a 
linear relationship with response, and a specific cut-off for 
response is unsuitable [28]. It is therefore not applicable for 
patient selection, although the probability of response can 
be determined.
in atrial fibrillation. Contrast-enhanced echocardiography 
for volume assessment can further reduce intraobserver and 
interobserver variability [16, 17]. An intravenous contrast 
agent can identify the endocardial borders more precisely. 
When used in either two- or three-dimensional echocardiog-
raphy, LV volumes determined by contrast are also more 
similar (less underestimated) to MRI [16]. Results on LVEF 
are conflicting, as both similar and improved correlations 
to MRI are reported using contrast-enhanced volumes com-
pared with conventional echocardiography [16–18].
Based on these findings, the cut-off for selection of 
patients eligible for CRT should depend on the imaging 
tool. Moreover, subgroups for LVEF 30–40 % could be 
incorporated in future guidelines [12]. Patients with LVEF 
above the current cut-off, but with a true left bundle branch 
block (LBBB), might benefit from CRT. Implementation 
of subgroups, in concordance with the role of QRS width 
in current guidelines, may reflect the role of LVEF in CRT 
more appropriately. However, evidence supporting CRT in 
subgroups based on LVEF needs to be further established.
Dyssynchrony
Selection criteria for patients eligible for CRT based on 
electrical or mechanical dyssynchrony show a preference 
for an electrical substrate [9]. Correcting mechanical dys-
synchrony without an electrical substrate has proven to be 
ineffective, as has been shown in large trials such as Echo-
CRT [7]. Moreover, after PROSPECT, it remains debated 
whether mechanical dyssynchrony is warranted as an indi-
cator for response to CRT, although the study design and 
applied dyssynchrony parameters are disputed [19]. Guide-
lines have so far been restricted to clinical and electrocar-
diographic selection criteria (i.e. QRS width and LBBB 
morphology). As previously mentioned, imaging tools are 
strictly necessary to determine LVEF. Mechanical dys-
synchrony proven by any echocardiographic parameter is 
not included in current guidelines. Patients with a class I 
indication (i.e. LBBB) will most certainly have a form of 
mechanical dyssynchrony when assessed by echo. Patients 
with a class III indication (i.e. QRS < 120 ms) and with 
proven dyssynchrony are no better or even worse with CRT 
[7, 20]. The additional value of dyssynchrony parameters 
might be in the class IIa or b groups. In these groups, with 
prolonged QRS width (> 120 or > 150 ms) and non-LBBB, 
visualised mechanical dyssynchrony could indicate a treat-
able substrate.
Mechanical dyssynchrony parameters (Table 1) should 
be based on a physiological principle, where early septal 
and delayed activation of the LV free wall causes disturbed 
LV intraventricular and interventricular interaction. An 
ideal parameter indicates a substrate that can be corrected 
by biventricular pacing. Prediction models for volumetric 
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diography, calculated by the time difference between peak 
velocity (Doppler) or contraction (Doppler and/or speckle 
tracking) of the basal septal and lateral wall [5]. SL delay 
thereby reflects both early septal and late lateral wall con-
traction caused by delayed free wall activation. Using tissue 
Doppler imaging, SL delay is measured by sampling in the 
basal septal and lateral wall, which is sensitive to sample 
placement [29]. As for all time-based parameters, defining 
the maximum peak is of importance. The maximal peak can 
be early or late, depending on the interaction with tether-
Deformation imaging
Deformation imaging or strain analysis with echocardiog-
raphy uses either tissue Doppler imaging or speckle track-
ing echocardiography. The latter is less angle dependent and 
covers the whole ventricular wall, in contrast to tissue Dop-
pler imaging, and is therefore more reliable for detection of 
delayed activated segments.
Septal to lateral wall delay (SL delay) is obtained by either 
tissue Doppler velocity imaging or speckle tracking echocar-
Table 1 Echocardiographic parameters for patient selection and/or response prediction
Param-
eter
Brief description Echocardiographic 
image
Cut-off Pros Cons Remarks
Apical 
rocking
Visual assessment of 
apical rocking motion
AP4CH viewa Yes/no [6, 25] Easy method Translating continuous 








Visual assessment of 
short septal motion dur-
ing beginning of systole
AP4CH view, zoomed on 
septum or PLAX









ence in onset of outflow 
of LV (LVPEP) and RV 
(RVPEP)
Pulsed-wave Doppler of 
LVOT and RVOT








responseConfounded by both 
LV and RV function 50 ms cut-off 
used in CARE-
HF trial [28]
SRSsept All positive deflections 
after initial shortening 
of the septum during 
systole
AP4CH view suitable 
for speckle tracking (B-
mode) zoomed and focus 
on septum





Relatively difficult for 
non-trained personnel
One trial found 










Strain pattern of the 
septum during systole
AP4CH view suitable 
for speckle tracking (B-
mode) zoomed and focus 
on septum
3 types (1 












SL delay Difference of time to 
peak velocity (or short-
ening) of (basal) septal 
and lateral wall
AP4CH view suitable 
for speckle tracking (B-
mode) or TDI velocity 
delay
≥ 65 ms [3, 5] Predicts volu-
metric response 
and outcome
Negative results in 
multicentre trial
Large influence of 
sampling
Time-to-peak based
SD-TTP Standard deviation of 
time to peak shorten-
ing (strain) or velocity 
(TDI) off all myocardial 
segments
AP4CH, AP2CH and 
APLAX view suitable 
for speckle tracking (B-
mode) or TDI
≥ 32 ms [3] Time-to-peak based Requires multi-
centre validationHigh image quality 
needed
SDI Time to minimal systolic 
volume of 16 segments
3D echocardiography 9.8 % [39] High predictive 
value for 
response




AP4CH apical four chamber view, B-mode brightness mode, GE General Electric, IVMD interventricular mechanical delay, LV left ventricle, 
LVOT left ventricular outflow tract, LVPEP left ventricular pre-ejection period, PLAX parasternal long axis, SDI systolic dyssynchrony index, 
SD-TTP standard deviation of time to peak shortening, RV right ventricular, RVOT right ventricular outflow tract, RVPEP right ventricular 
pre-ejection period, SL-delay septal to lateral wall delay of time to peak shortening, SRSsept systolic rebound stretch of the septum, TDI tissue 
Doppler imaging.
Neth Heart J (2016) 24:25–38
29
tric Healthcare, Milwaukee, USA [36]. Intraobserver and 
interobserver coefficients of variation are relatively high 
for SRSsept (19.5 and 16.3 %, respectively) [4]. Despite 
the small number of clinical trials, all agree on the poten-
tial strength of septal strain parameters derived by speckle 
tracking echocardiography (Table 1; [32, 34, 37, 38]). A 
multicentre trial is required to prove their benefit in clinical 
decision making.
Dyssynchrony can also be assessed by three-dimensional 
echocardiography (3DE). The predominant 3DE parameter 
is the systolic dyssynchrony index, using the standard devi-
ation of difference from a reference time point in the QRS 
complex to minimal systolic volume of 16 segments. Sys-
tolic dyssynchrony index (mean cut-off 9.8 %) was able to 
predict treatment response with a sensitivity and specificity 
of 93 and 75 % respectively [39]. The intra-class correlation 
coefficients for intraobserver and interobserver variability 
were high (0.95 and 0.92 respectively). Nevertheless, the 
echocardiographic image quality (i.e. spatial and tempo- 
ral resolution) needs to be adequate for analysis, which is 
not always feasible. QRS triggering should also be ade-
quate, as triggering after QRS onset will miss early septal 
contraction, overestimate the onset and therefore underesti-
mate time-to-peak values. Moreover, these parameters have 
been tested in single-centre studies, and therefore require 
validation in a multicentre trial. The diagnostic power of the 
systolic dyssynchrony index can therefore be overrated, as 
has been observed for previous parameters (e.g. SL delay) 
[3, 5].
Optimising lead position
Radial strain obtained with speckle tracking echocardiogra-
phy from parasternal short axis images prior to implantation 
can indicate segments with delayed peak contraction. Dur-
ing implantation, LV lead placement can be guided to these 
segments, resulting in a remote, adjacent (i.e. neighbour-
ing), or concordant placement, based on the 17-segment 
model of the American Heart Association. Observational 
studies have shown that a concordant or adjacent position 
to the latest contracting segment is superior to a remote 
ing myocardium and ventricular dynamics. Septal defor-
mation can have a late maximum peak, while contraction 
starts early, resulting in an earlier first peak (baseline septal 
strain in Fig. 3). A dyssynchronous ventricle can therefore 
be deemed synchronous. Moreover, despite the promising 
results of single-centre studies, so far no multicentre trial 
has proved the diagnostic power of SL delay [3].
Most deformation parameters use time delays in peak 
contraction, either absolute, relative or as a standard devia-
tion, to determine evidence of dyssynchrony [30]. These 
parameters suffer from the same definition-based limita-
tions as SL delay. Parameters that incorporate the entire 
strain curve are therefore more promising. Moreover, high-
quality images are required to determine segmental differ-
ences, which is not always feasible, especially in patients 
with dilated ventricles due to heart failure. The interventric-
ular septum is therefore of particular interest, as echocardio-
graphic imaging of the septum is almost always feasible and 
reproducible. Its central position in the ultrasound window 
guarantees adequate image quality. Moreover, the septum 
provides information on interventricular interaction as well 
as intraventricular properties. Derived parameters, such as 
SRSsept or identification of septal strain patterns, are prom-
ising as predictors of outcome (Fig. 3 and Table 2; [4, 31, 
32]). SRSsept is the total amount of systolic rebound stretch, 
after initial shortening of the septum. Early septal shorten-
ing disrupted by contralateral delayed free wall contrac-
tion causes rebound stretch. SRSsept thereby assesses the 
amount of wasted work for the septum that can be recruited 
by CRT. Septal dyssynchrony can show multiple typical 
patterns, of which Leenders et al. discriminated three types 
[33]. These patterns (and SRSsept) are even influenced by 
myocardial viability and predict both clinical and volumet-
ric response to CRT (Fig. 3; [33, 34]). Risum et al. recently 
demonstrated the role of LV strain pattern recognition on top 
of electrocardiographic predictors for outcome [35]. How-
ever, results depend on the ultrasound machine and speckle 
tracking echocardiography software used. The majority of 
algorithms to determine myocardial strain are unknown 
and lack validation. Inter-vendor differences are known 
and limit translation to other ultrasound machines than the 
most commonly published, i.e. GE EchoPac, General Elec-
Fig. 2 Central illustration. Role 
of echocardiography in CRT. 
Echocardiography can be used 
to select patients by volume and 
subsequent ejection fraction 
assessment and by dyssynchrony 
parameters based on Doppler and/
or strain analysis. Doppler can 
also optimise CRT settings, while 
strain analysis could support LV 
lead optimisation strategies
 
Neth Heart J (2016) 24:25–38
30
of death and hospitalisation for heart failure, TARGET: 
22 vs. 42 % and STARTER: 14 vs. 21 %). A large number 
of leads in the unguided group were by chance placed in 
a favourable position. Per-protocol analysis of both studies 
showed that patients (guided or unguided) with concordant 
or adjacently placed leads had a better response and out-
come [1, 42].
Another advantage of strain analysis is information on 
myocardial viability by peak strain values. Scarred regions 
are known to have lower strain amplitudes, and pacing 
in a region of scar tissue correlates to non-response [43]. 
position, in terms of reverse remodelling, death and hos-
pitalisation during 2 years of follow-up [40, 41]. Targeting 
the latest contracting segment with radial strain has been 
implemented in two randomised clinical trials, the TARGET 
and STARTER trial. Patients were randomised to targeted or 
conventional LV lead placement [1, 42]. Targeted placement 
led to a higher percentage of concordant or adjacent posi-
tions and showed improvement in both volumetric response 
(LV change in end-systolic volume, TARGET: − 30 ± 29 vs. 
− 20 ± 25 % and STARTER: − 46 ± 33 vs. − 26 ± 23 ml) and 
clinical outcome (percentage of patients reaching endpoint 
Fig. 3 Schematic representation of apical rocking and septal flash. 
Schematic representation of the left ventricle in echocardiographic api-
cal four-chamber view, showing both septal flash and apical rocking 
due to LBBB-induced mechanical dyssynchrony. a Early septal con-
traction stretches the lateral wall and rocks the apex to the left, while 
the septum thickens and moves inwards. b Late lateral wall contraction 
stretches the septum and rocks the apex to the right. c Relaxation of the 
lateral wall with continuing septal contraction, while the apex moves 
to its original position
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and 72 % respectively, compared with MRI with delayed 
enhancement [46]. Peak strain values might be underes-
timated in a dyssynchronous ventricle, as both pre- and 
rebound stretch would decrease the absolute peak value.
High image quality is important for reliable strain anal-
ysis, which is relatively difficult to obtain in typical CRT 
patients with dilated left ventricles. Segments distal from 
the echo probe (i.e. basal and mid-inferoseptal, inferior 
and inferolateral segments) are prone to noise, and there-
fore result in more random strain curves. Even if quality 
is sufficient, time-to-peak strain values can be quite com-
parable between segments, as can be appreciated in Fig. 4. 
Both abovementioned trials excluded segments with peak 
strain < 10 %, thereby excluding potentially scarred seg-
ments, which may have contributed significantly to the posi-
tive effects of echo-guided lead positioning. Sub-analysis 
showed that absence of scar near the LV lead was a strong 
predictor for volumetric response and reduced all-cause 
mortality in the TARGET trial [44]. Moreover, sub-analysis 
of the STARTER trial indicated that echo-guided LV lead 
placement improved survival especially in patients with 
ischaemic cardiomyopathy [45]. Notwithstanding these 
results, peak radial strain has shortcomings as an indicator 
for viability, as the sensitivity and specificity were only 33 
Table 2 Studies on septal dyssynchrony parameters predicting response to CRT
First author Design Subjects (n) Parameter and 
cut-off
Response prediction 
(≥ 15 % ΔESV)
Outcome Strengths and/or 
limitations
De Boeck [4] Prospective single 
centre
62 SRSsept > 4.7 % Sens/spec: 81 %/81 %, 
AUC: 0.938 ± 0.035, B: 




ity (COV: 14.2 and 
15.6 %)
Leenders [31] Prospective single 
centre
101 SRSsept > 4.7 % Multivariate analysis, 
B: 3.78, p < 0.001
Survival (death, 
LVAD or trans-




Chan [38] Prospective single 
centre
43 SRSsept > 4.7 % AUC: 0.862 ± 0.061a No multivariate 
analysis






SRSsept assessed as 
continuous variable. 
No specific cut-off 
used
Ghani [32] Retrospective single 
centre
138 SRSsept > 4.0 % Sens/spec: 66 %/66 %, 
AUC: 0.70
Data on outcome 
not published (al-
though registered)
Analysis on AP4CH 
instead of septal 
single wall
Leenders [33] Retrospective single 
centre
132 Septal deforma-
tion patterns (3 
types)
Type 1 and 2 predict 
response vs type 3 
ΔESV: 37 ± 20 & 





Marechaux [34] Prospective single 
centre
101 Septal deforma-
tion patterns (3 
types)
Responders: pattern 
1&2 vs 3: 92 vs. 59 %, 




(death or HF hos-
pitalisation): Pat-
tern 1&2 vs. 3: 95 
vs 75 %, p = 0.01
Relatively short 
follow-up




Sens/spec: 91 %/95 % Complex pattern 
description






increases 4 year 
risk of death,  
HF hospitalisation, 




Studies on septal dyssynchrony parameters, derived from speckle tracking echocardiography, predicting response to cardiac resynchronization 
therapy. All studies are single centre, prospective trials.
AUC area under the curve in ROC analysis, B beta-coefficient, COV coefficient of variation, ΔESV difference in end-systolic volume, HF heart 
failure, HR hazard ratio, HTx heart transplantation, LBBB left bundle branch block, LVAD left ventricular assist device, n number of patients, p 
p-value, sens sensitivity, spec specificity, SRSsept systolic rebound stretch of the septum.
awhen added to a model with clinical characteristics (gender, LBBB, QRS duration, heart failure aetiology).
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identical between recordings, which means that changes in 
heart rhythm disturb the result. 3DE could be an answer to 
the above-mentioned difficulties, assessing the entire left 
Using longitudinal strain could be a solution, it has more 
pronounced regional differences and is more robust than 
radial strain [47]. Lastly, loading conditions need to be 
Fig. 4 Example of echocardiographic data obtained from a responder 
to CRT. Apical four-chamber view, colour Doppler, septal strain and 
pulsed-wave Doppler acquisition of a responder to CRT, before, and 
6 and 12 months after implantation. Note the continuous decrease in 
LV volume, decrease in mitral regurgitation, improvement in septal 
strain and decrease in IVMD over time. These data suggest a continu-
ous process of reverse remodelling. Septal strain: yellow, light blue 
and green lines represent basal, mid and apical inferoseptal segmental 
strain, respectively. The three curves represent the segments illustrated 
in baseline echocardiogram in the upper left panel. The white dashed 
curve represents the average septal strain. SRSsept is marked red, as 
all rebound stretch after initial shortening, during systole. IVMD is 
represented by pulsed-wave Doppler signals of the left and right ven-
tricular outflow tract. EDV end-diastolic volume, ESV end-systolic 
volume, EF ejection fraction, ΔESV change in ESV compared with 
baseline, SRS systolic rebound stretch, LVPEP left ventricular pre-
ejection period, RVPEP right-ventricular pre-ejection period, IVMD 
interventricular mechanical delay. Volumes are derived by biplane 
Simpson’s method
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These limitations currently make echocardiography unsuit-
able for optimisation.
Defining response with echocardiography
For response prediction, an echocardiogram is performed at 
least 6 months after CRT implantation, to compare volu-
metric status pre- and post-implantation (after a period 
of preferred reverse remodelling). Reverse remodelling 
is characterised by a decrease in LV volume. A ≥ 15 % 
decrease in LV end-systolic volume is commonly used to 
define response to CRT, or if lower, non-response. Although 
clinical response to CRT is multifactorial and is observed 
in patients without remodelling, volumetric change (i.e. 
decrease in end-systolic volume) predicts clinical response 
and prognosis of CRT patients. A larger decrease in end-
systolic volume means fewer hospitalisations for heart fail-
ure and a lower mortality rate. When divided into subgroups 
(negative, non-responder, normal, and super-responder), 
there is an upscaling effect. Super-responders had almost 
no events during 5 years of follow-up, while non and nega-
tive responders have progressive heart failure and subse-
quent events [56]. Moreover, end-systolic volume decrease 
is preferred over clinical parameters (NYHA class, 6-min-
ute walking distance, and quality of life score [57]. Qual-
ity of life and reverse remodelling do not always overlap, 
as patients can show improvement in one without the other 
[58]. Clinical parameters should not be disregarded, as an 
increase in quality of life or NYHA class can be as important 
to a patient as survival. Health status responders, defined by 
the Kansas City Cardiomyopathy Questionnaire (KCCQ) 
score, have a 76 % lower risk of subsequent events [58]. A 
reason for the missing link could be the time of volumetric 
assessment [59]. Studies have shown that reverse remod-
elling is a continuous process, with patients still showing 
improvement after a year of CRT (Fig. 3; [28]). Patients 
who are below the threshold of response at 6 months could 
become responders afterwards. Even patients with a proven 
response can have a reversal in effect, as volumetric assess-
ment 14 months after initial response can show an increase 
in end-systolic volume to pre-CRT levels [60]. Assessment 
after 14 months of CRT proved to be a better predictor of 
major adverse cardiac events. These results necessitate a 
continuous re-evaluation of volumetric status.
Future directions
Echocardiography could play a larger role in CRT, espe-
cially if 3D acquisition were to become more feasible for 
clinical practice. Increased spatial and temporal resolution 
could make 3DE applicable for fast acquisition of volumet-
ventricle in a single recording, although current techniques 
require multiple consecutive beats [48].
Optimisation of device configuration
Echocardiography can be used to optimise atrioventricular 
and/or interventricular delays (AV/VV delay). AV-delay 
optimisation influences ventricular filling and may cause 
fusion with intrinsic conduction, thereby also influencing 
intraventricular and interventricular interaction. VV-delay 
optimisation also influences intraventricular and interven-
tricular dynamics, leading to more homogenous LV con-
traction. Optimisation methods used in previous trials are: 
iterative or Ritter method of mitral valve inflow character-
istics, velocity time integral of Doppler echocardiography 
of LVOT, and dyssynchrony indices using visual assess-
ment, speckle tracking echocardiography or tissue Doppler 
imaging. Optimisation influences acute haemodynamic and 
mechanical interaction [49]. Van Deursen et al. showed the 
interaction between electrocardiography, strain analysis by 
speckle tracking echocardiography, IVMD, velocity time 
integral of the LVOT, and blood pressure based on finger 
plethysmography, while adjusting either the AV or VV delay 
in CRT patients [49].
Optimisation has comparable results on long-term out-
come to standard or fixed delays [50]. The SMART-AV 
study, for example, showed no benefit of echocardiographic 
optimisation with an iterative method compared with a fixed 
AV delay of 120 ms [2]. Although Mullens et al. showed 
that 47 % of clinical non-responders (no significant New 
York Heart Association (NYHA) class or 6-minute walking 
test improvement) had a suboptimal AV delay, no trials so 
far have been published on the effects of optimisation on 
change in volumetric response [51]. Except for the unpub-
lished RESPONSE-HF study, which showed no benefit of 
VV-delay optimisation in non-responders in a preliminary 
report [50]. All echocardiographic optimisation methods 
optimise relatively small changes (10–20 ms difference 
in AV and/or VV delay) with a parameter prone to noise. 
Patient repositioning, breathing, echocardiographic probe 
displacement, and other physiological disturbances all influ-
ence results. Even if one were to overcome the first three, 
reliable and reproducible measurement requires numerous 
iterations [52, 53]. This implies even more time-consum-
ing protocols, which are unlikely to be used by clinicians. 
Moreover, blinding observers for settings using the iterative 
method leads to an even larger spread in optimums com-
pared with unblinded optimisation, suggesting a significant 
amount of observer bias [47]. The optimal AV delay can 
also differ during different physiological conditions (i.e. rest 
and exercise) and may change due to remodelling [54, 55]. 
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